Page last updated: 2024-11-04

sulforaphane and Congenital Pachyonychia

sulforaphane has been researched along with Congenital Pachyonychia in 2 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Research Excerpts

ExcerptRelevanceReference
"Pachyonychia congenita is caused by mutations in keratin genes and typified by dystrophic lesions affecting nails, glands, oral mucosa, and palmar-plantar epidermis."1.48Sexual Dimorphism in Response to an NRF2 Inducer in a Model for Pachyonychia Congenita. ( Coulombe, PA; Hakim, JMC; Kerns, ML; Lu, RG; Zieman, A, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kerns, ML2
Hakim, JMC1
Zieman, A1
Lu, RG2
Coulombe, PA2
Hakim, JM1
Guo, Y1
Berroth, A1
Kaspar, RL1

Other Studies

2 other studies available for sulforaphane and Congenital Pachyonychia

ArticleYear
Sexual Dimorphism in Response to an NRF2 Inducer in a Model for Pachyonychia Congenita.
    The Journal of investigative dermatology, 2018, Volume: 138, Issue:5

    Topics: Animals; Disease Models, Animal; Estrogen Receptor alpha; Female; Glutathione; Humans; Isothiocyanat

2018
Oxidative stress and dysfunctional NRF2 underlie pachyonychia congenita phenotypes.
    The Journal of clinical investigation, 2016, 06-01, Volume: 126, Issue:6

    Topics: Animals; Disease Models, Animal; Glutathione; Humans; Isothiocyanates; Keratin-16; Keratoderma, Palm

2016